James Van Der Beek died at 48 after being diagnosed with colorectal cancer. Here's what to know about common symptoms, which can be subtle. [Business Insider]
Guardant Health to Participate in Upcoming Investor Conferences
Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions [Yahoo! Finance]
Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions
Assessing Guardant Health (GH) Valuation After FDA Guardant360 CDx Approval And New Merck Collaboration [Yahoo! Finance]